Related Experiment Video
Updated: May 11, 2026

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
Published on: June 17, 2015
The Auditory Brainstem Response Diagnoses Alzheimer-Like Disease in the 5xFAD Mouse Model
Daxiang Na1, Yidan Yang2, Li Xie3
1Department of Neuroscience, Ernst J. Del Monte Institute for Neuroscience, University of Rochester Medical Center, Rochester, New York 14642.
Auditory brainstem response (ABR) changes can reliably diagnose early Alzheimer's disease (AD) in mice using machine learning. This noninvasive biomarker may aid in early AD detection and personalized treatment strategies.
Area of Science:
- Neuroscience
- Biomarkers
- Machine Learning
Background:
- Early Alzheimer's disease (AD) diagnosis is crucial for personalized treatment.
- Auditory processing deficits are common in mild cognitive impairment, a precursor to AD.
- The diagnostic potential of auditory processing for AD remains underexplored.
Purpose of the Study:
- To investigate the efficacy of auditory brainstem response (ABR) measurements as a diagnostic biomarker for early-stage Alzheimer's disease (AD).
- To explore the utility of machine learning algorithms in interpreting ABR data for AD diagnosis.
- To identify potential neural correlates of auditory deficits in AD.
Main Methods:
- Utilized amyloidosis mouse models exhibiting memory decline.
- Recorded auditory brainstem responses (ABR) to auditory stimuli.
- Applied machine learning algorithms to ABR data for disease diagnosis.
- Conducted histological analyses to correlate neural changes with behavioral and auditory findings.
Main Results:
- Machine learning successfully diagnosed disease based on ABR changes in mice with amyloidosis and memory decline.
- Analysis indicated that upper auditory pathway structures, such as the inferior colliculus, are likely sources of auditory defects.
- Neuroinflammation and plaque deposition in these regions correlated temporally with memory loss.
Conclusions:
- Auditory brainstem response (ABR) measurements show promise as a rapid, low-cost, noninvasive biomarker for early Alzheimer's disease (AD) detection.
- Machine learning interpretation of ABR data can facilitate reliable AD diagnosis.
- Further evaluation of ABR as an adjunct diagnostic tool for early-stage AD is warranted.
More Related Videos
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
08:25Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
Published on: April 19, 2021